Latest News

October 11, 2012
When Shinya Yamanaka won the Nobel Prize in Medicine, colleagues at UCSF and the Gladstone Institutes and scientists from his lab gathered Monday afternoon to cheer the laureate and raise champagne toasts, while he shared in the celebration via live video streaming from halfway across the globe.
October 10, 2012
A new study that represents a significant first step in exploring the potential of stem cells to treat neurological disease is a “natural outgrowth” of a longstanding culture of interdisciplinary collaboration in UCSF neonatology — a culture that UCSF Benioff Children's Hospital physicians David Rowitch and Donna Ferriero work hard to sustain.
October 09, 2012
Stem cell researcher Shinya Yamanaka, MD, PhD, reached in Kyoto shortly after being named winner of the 2012 Nobel Prize for Physiology or Medicine, said he was doing some housecleaning when the call came in, and was “very surprised.”
October 08, 2012
Since 1981, when UCSF’s Gail Martin, PhD, co-discovered embryonic stem cells in mice and coined the term embryonic stem cell, UCSF has been a key player in the stem cell field. Today, Shinya Yamanaka became the fifth UCSF scientist to win the Nobel Prize.
October 08, 2012
Here are answers to frequently asked questions about induced pluripotent stem cells, or iPS cells, the type of cell that has been reprogrammed from an adult cell, such as a skin or blood cell.
October 08, 2012
Colleagues at the Gladstone and UCSF celebrated the news on Monday that Shinya Yamanaka won the Nobel Prize in Medicine for his discovery that has transformed the field of stem cell research.
October 08, 2012
Shinya Yamanaka, MD, PhD, a senior investigator at the Gladstone Institutes and a professor of anatomy at UCSF, has won the 2012 Nobel Prize in Physiology or Medicine for his discovery of how to transform ordinary adult skin cells into cells that are capable of developing into any cell in the human body.
September 13, 2012
Biomedical researchers at UCSF have won five of 51 prestigious National Institutes of Health Director’s New Innovator awards for high-risk, high-reward research, each receiving up to $1.5 million over five years.
January 10, 2012
Medical geneticist Ophir Klein's studies of stem cells in tooth development and of stem cell changes in the gut may lead to new strategies for regenerating teeth and for treating craniofacial abnormalities.
December 20, 2011
From improved heart failure and HIV treatment, to gene therapy and stem cell discoveries, here is just a sampling from 2011 of research advances at UCSF that are keeping the research pipeline flowing toward  better healthcare -- including greater patient safety, more efficient healthcare delivery, and improved outcomes for patients.

Pages